Familial Chylomicronemia Syndrome research hub

A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Participants With Familial Chylomicronemia Syndrome (FCS)

This study is looking at a new medicine called Olezarsen for people with a rare condition called Familial Chylomicronemia Syndrome (FCS). It's a continuation of an earlier study, aiming to see more about how safe and effective Olezarsen is over a longer time.